What are the type I (acidic) and type II (basic‑to‑neutral) keratin families, which keratins belong to each, how do they pair in stratified versus simple epithelia, and what are the clinical implications of mutations in these keratin pairs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Type I and Type II Keratins: Classification, Pairing, and Clinical Implications

Keratin Classification

Keratins are intermediate filament proteins divided into two distinct families: Type I (acidic) keratins and Type II (basic-to-neutral) keratins, which must pair together as obligate heteropolymers to form functional cytoskeletal filaments in epithelial cells. 1, 2

Type I Keratins (Acidic)

  • 28 genes encoding acidic keratins located on chromosome 17 3, 4
  • Smaller molecular weight proteins
  • Must pair with Type II keratins to form functional filaments 1, 2

Type II Keratins (Basic-to-Neutral)

  • 26 genes encoding basic-to-neutral keratins located on chromosome 12q13 3, 4
  • Larger molecular weight proteins
  • Eight Type II keratin genes are clustered together at 12q13, with their organization reflecting evolutionary relationships 3

Keratin Pairing Patterns

Stratified Epithelia (Skin)

In stratified epithelia, the primary keratin pair expressed in basal keratinocytes is K5 (Type II) and K14 (Type I). 5

  • Basal layer: K5/K14 pair provides mechanical stability to basal keratinocytes 5
  • Suprabasal layers: K1 (Type II) and K10 (Type I) pair in differentiated keratinocytes 1
  • Palmoplantar epidermis: K9 (Type I) pairs with K1 in thick skin 1
  • Hair follicles: Approximately half of all 54 functional keratin genes are restricted to various hair follicle compartments 4

Simple Epithelia (Internal Organs)

In simple epithelia of digestive organs, K8 (Type II) and K18 (Type I) form the primary keratin pair. 6, 3

  • K8/K18 expressed in liver, pancreas, and intestinal epithelium 6
  • These genes are located adjacent to each other in the Type II keratin cluster on chromosome 12 3

Clinical Implications of Keratin Mutations

Epidermolysis Bullosa Simplex (EBS) - Basal Type

Mutations in K5 (KRT5) or K14 (KRT14) genes cause basal EBS, resulting in intraepidermal blistering within basal keratinocytes due to cellular fragility. 5

  • Mechanism: Dominant-negative mutations disrupt keratin filament cytoskeleton, making cells less resilient to mechanical trauma 1
  • Clinical subtypes:
    • EBS localized (palms/soles only) 5
    • EBS generalized severe 5
    • EBS generalized intermediate 5
  • Inheritance: Autosomal dominant in most cases 1, 4

Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)

Mutations in K1 or K10 genes cause suprabasal keratinocyte fragility with abnormal keratin filament clumping in differentiated layers. 1

  • Blistering occurs above the basal layer due to suprabasal keratin pair dysfunction 1

Epidermolytic Palmoplantar Keratoderma

Mutations in K9 (Type I) or K1 (Type II) cause thickened, fragile skin on palms and soles. 1

  • K9 is specifically expressed in palmoplantar epidermis 1

Pachyonychia Congenita

Mutations in K6a, K6b, K16, or K17 cause nail dystrophy, palmoplantar keratoderma, and oral leukokeratosis. 1

  • These keratins are expressed in specific epithelial compartments including nail beds 1

Digestive System Disorders

Mutations in K8 or K18 predispose to cryptogenic cirrhosis and increase susceptibility to liver injury. 1, 6

  • K8/K18 mutations represent risk factors for acute and chronic liver diseases 6, 2

Key Clinical Pitfalls

Dominant-Negative Effect

Most keratin mutations act in a dominant-negative manner, meaning the mutant protein disrupts the function of normal keratin proteins, making gene therapy challenging. 1

  • Simply adding normal keratin genes is insufficient; the mutant gene must be inactivated 1

Tissue-Specific Expression

The clinical phenotype depends entirely on which keratin pair is mutated, as keratins are expressed in tissue- and differentiation-specific patterns. 2, 4

  • K5/K14 mutations affect stratified epithelia (skin blistering) 5
  • K8/K18 mutations affect simple epithelia (liver disease) 6
  • K1/K10 mutations affect suprabasal epidermis (ichthyosis) 1

Prenatal Diagnosis

For severe keratin disorders, prenatal diagnosis from chorionic villus samples is available using genomic DNA mutation detection methods. 1

References

Research

The molecular genetics of keratin disorders.

American journal of clinical dermatology, 2003

Research

Skin Keratins.

Methods in enzymology, 2016

Research

The human keratins: biology and pathology.

Histochemistry and cell biology, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.